Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization
Dry-coated microprojections can deliver vaccine to abundant antigen-presenting cells in the skin and induce efficient immune responses and the dry-coated vaccines are expected to be thermostable at elevated temperatures. In this paper, we show that we have dramatically improved our previously report...
Saved in:
Published in | Journal of controlled release Vol. 152; no. 3; pp. 349 - 355 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier B.V
30.06.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Dry-coated microprojections can deliver vaccine to abundant antigen-presenting cells in the skin and induce efficient immune responses and the dry-coated vaccines are expected to be thermostable at elevated temperatures. In this paper, we show that we have dramatically improved our previously reported gas-jet drying coating method and greatly increased the delivery efficiency of coating from patch to skin to from 6.5% to 32.5%, by both varying the coating parameters and removing the patch edge. Combined with our previous dose sparing report of influenza vaccine delivery in a mouse model, the results show that we now achieve equivalent protective immune responses as intramuscular injection (with the needle and syringe), but with only 1/30th of the
actual dose. We also show that influenza vaccine coated microprojection patches are stable for at least 6
months at 23
°C, inducing comparable immunogenicity with freshly coated patches. The dry-coated microprojection patches thus have key and unique attributes in ultimately meeting the medical need in certain low-resource regions with low vaccine affordability and difficulty in maintaining “cold-chain” for vaccine storage and transport.
Influenza vaccine coated microprojection patches are stable for at least 6
months at 23
°C, inducing comparable immunogenicity with freshly coated patches.
[Display omitted] |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.jconrel.2011.02.026 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0168-3659 1873-4995 |
DOI: | 10.1016/j.jconrel.2011.02.026 |